Cargando…
Advances in co-opting anti-depressant drugs in glioma therapy
A study by Chryplewicz et al. demonstrated the efficacy of combining tricyclic antidepressant imipramine and anti-VEGF therapy in treating genetically engineered glioma models. Dual therapy synergistically improved vascular integrity, increased autophagy, and modulated the myeloid and lymphoid compa...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9797942/ https://www.ncbi.nlm.nih.gov/pubmed/36543105 http://dx.doi.org/10.1016/j.xcrm.2022.100837 |
_version_ | 1784860796797321216 |
---|---|
author | Pant, Ayush Lim, Michael |
author_facet | Pant, Ayush Lim, Michael |
author_sort | Pant, Ayush |
collection | PubMed |
description | A study by Chryplewicz et al. demonstrated the efficacy of combining tricyclic antidepressant imipramine and anti-VEGF therapy in treating genetically engineered glioma models. Dual therapy synergistically improved vascular integrity, increased autophagy, and modulated the myeloid and lymphoid compartments in glioma. |
format | Online Article Text |
id | pubmed-9797942 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-97979422022-12-30 Advances in co-opting anti-depressant drugs in glioma therapy Pant, Ayush Lim, Michael Cell Rep Med Spotlight A study by Chryplewicz et al. demonstrated the efficacy of combining tricyclic antidepressant imipramine and anti-VEGF therapy in treating genetically engineered glioma models. Dual therapy synergistically improved vascular integrity, increased autophagy, and modulated the myeloid and lymphoid compartments in glioma. Elsevier 2022-12-20 /pmc/articles/PMC9797942/ /pubmed/36543105 http://dx.doi.org/10.1016/j.xcrm.2022.100837 Text en © 2022 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Spotlight Pant, Ayush Lim, Michael Advances in co-opting anti-depressant drugs in glioma therapy |
title | Advances in co-opting anti-depressant drugs in glioma therapy |
title_full | Advances in co-opting anti-depressant drugs in glioma therapy |
title_fullStr | Advances in co-opting anti-depressant drugs in glioma therapy |
title_full_unstemmed | Advances in co-opting anti-depressant drugs in glioma therapy |
title_short | Advances in co-opting anti-depressant drugs in glioma therapy |
title_sort | advances in co-opting anti-depressant drugs in glioma therapy |
topic | Spotlight |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9797942/ https://www.ncbi.nlm.nih.gov/pubmed/36543105 http://dx.doi.org/10.1016/j.xcrm.2022.100837 |
work_keys_str_mv | AT pantayush advancesincooptingantidepressantdrugsingliomatherapy AT limmichael advancesincooptingantidepressantdrugsingliomatherapy |